“I have been routinely utilizing VUNO Med®-DeepBrain® in my clinical practice for the past 3 years. The Brain Volumetry Results Report, generated from 3D T1 MPRAGE images, can be easily obtained within a few minutes. I typically employ this software for interpreting brain MRI in patients with early-stage or diagnosed Alzheimer’s disease. It provides valuable objective information that cannot be recognized through visual assessment alone, such as subtle atrophic changes in the hippocampus or asymmetric volume changes in both cerebral hemispheres.
VUNO Med®-DeepBrain® has also been beneficial in diagnosing hippocampal sclerosis in patients with seizures and in precise localization of cortical dysplasia based on the cortical thickness data it provides.
Furthermore, VUNO Med®-DeepBrain® goes beyond diagnosis by automating brain volume segmentation. This enables me to analyze brain structures in healthy subjects including pediatrics, providing valuable insights into brain volume variations and development.
In conclusion, VUNO Med®-DeepBrain® has become an indispensable tool in my clinical practice. It not only enhances clinical diagnosis but also facilitates research. The ability to perform brain volumetry with this software provides novel information comparable to that obtained from a new MRI sequence.”